2m 2m 2m 2m 2m 2m 2m
Viking Therapeut (VKTX)
NASDAQ
$32.03+$0.04 (+0.14%)
Price as of Sep 11, 2026 7:59 PM EDT- $3.7BMarket Cap
- 28.90%1-Year Change
- BiotechnologyIndustry
Viking Therapeut (VKTX)
$32.03+$0.04 (+0.14%)
VKTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $31.98 | ||
Change | -$0.15 (-0.47%) | ||
Open | $32.26 | ||
High | $33.05 | ||
Low | $31.70 | ||
Previous Close | $32.13 | ||
Volume | 2,207,193 | ||
30-Day Average Volume | 1,826,437 | ||
1-Week Change | -8.29% | ||
1-Month Change | -5.38% | ||
1-Year Change | 28.90% | ||
3-Year Change | 102.66% | ||
5-Year Change | 384.55% | ||
Fundamentals | |||
Shares Outstanding | 116.7M | ||
Total Assets | $521.9M | ||
Market Cap | $3.7B | ||
Enterprise Value | $3.6B | ||
Period: QTR TTM FY | |||
Revenue | $30,000.00 | ||
Net Income | -$128.0M | ||
Free Cash Flow | -$125.2M | ||
EBIT | -$128.0M | ||
EBITDA | -$128.0M | ||
Net Working Capital | $407.9M | ||
EPS | -$1.10 | ||
Enterprise Value/EBITDA | -28 | ||
Enterprise Value/Revenue | 120,160 | ||
P/B | 9 | ||
P/E | -29 | ||
PEG | -1 | ||
Price/Free Cash Flow | -30 | ||
Price/Operating Cash Flow | -30 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue